In the CRISPR Stem Cell Differentiation Market, the largest technology share in 2026 is held by CRISPR-Cas9 Editing, at 42.9%. The Regenerative Medicine segment leads by application with 32.3%. By stem cell type, 32.4% is attributed to Induced Pluripotent Stem Cells (iPSCs).